Summary
Kristian Kjærgaard is a seasoned drug development leader with a PhD in Molecular Biology and over 20 years’ experience shepherding biologics from discovery to clinical development, including 12 years in Novo Nordisk’s Biopharmaceutical Research Unit and senior program roles at Lundbeck and Ascendis Pharma. He has led large, multicultural cross-functional teams across Denmark, China, the US and beyond, delivering therapeutic monoclonal antibodies and CNS and oncology candidates into IND and Phase I stages. Skilled in project strategy, IP and due diligence, Kristian combines deep hands-on antibody science with governance-level stakeholder management and regulatory interactions. He is a proven innovator and named inventor on multiple patents, reflecting a track record of translating complex biology into protectable assets. Colleagues rely on his pragmatic risk mitigation, ability to align global affiliates, and comfort navigating scientific and commercial trade-offs. Less obvious: his career blends early technical benchwork—developing display and expression systems—with later executive program leadership, giving him rare end-to-end perspective.
12 years of coding experience
24 years of employment as a software developer
Doctor of Philosophy (Ph.D.), Molecular Biology, Doctor of Philosophy (Ph.D.), Molecular Biology at Technical University of Denmark
Danish, English